Anthem Biosciences Limited (NSE:ANTHEM)
773.00
+6.85 (0.89%)
Jun 23, 2026, 3:30 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 430.28 billion as of June 23, 2026.
Market Cap
430.28B
Enterprise Value
421.43B
Revenue
21.24B
Ranking
n/a
PE Ratio
73.46
Stock Price
773.00
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 430.28B, an increase of 4.90%. That is a compound annual growth rate of 5.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 430.28B | 17.60% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 672.43B |
| OneSource Specialty Pharma | 184.42B |
| Concord Biotech | 137.58B |
| Blue Jet Healthcare | 88.92B |
| Supriya Lifescience | 75.03B |
| Zota Health Care | 45.29B |
| Panacea Biotec | 32.85B |
| Dishman Carbogen Amcis | 26.77B |